Axon Enterprise, Inc. Director Sells 125,599.32 in Stock
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Slightly above 55% of Sio Gene's investors are presently thinking to get in. The analysis of current outlook of investing in Sio Gene Therapies suggests that some traders are interested regarding Sio Gene's prospects. Sio Gene's investing sentiment can be driven by a variety of factors including economic data, Sio Gene's earnings reports, geopolitical events, and overall market trends.
Sio |
Axon Enterprise, Inc. Director Caitlin Elizabeth Kalinowski sold 591 shares of Axon Enterprise stock in a transaction dated Friday, March 3rd. The shares were sold at an average price of 212.52, for a total transaction of 125,599.32. Following the transaction, the director now directly owns 8,179 shares of the companys stock,
Read at thelincolnianonline.com
 |
Sio Gene Fundamental Analysis
We analyze Sio Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Sio Gene is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Sio Gene Therapies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sio Gene stock to make a market-neutral strategy. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics with similar companies.
Peers
Sio Gene Related Equities
| SRZN | Surrozen | 19.37 | ||||
| ALGS | Aligos Therapeutics | 10.96 | ||||
| MNPR | Monopar Therapeutics | 8.84 | ||||
| VINC | Vincerx Pharma | 7.69 | ||||
| CTMX | CytomX Therapeutics | 3.92 | ||||
| VCNX | Vaccinex | 2.44 | ||||
| ASMB | Assembly Biosciences | 1.25 | ||||
| RZLT | Rezolute | 1.00 | ||||
| XOMA | XOMA Corp | 0.84 | ||||
| NUVB | Nuvation Bio | 0.35 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| TARA | Protara Therapeutics | 0.99 | ||||
| SABS | SAB Biotherapeutics | 1.02 | ||||
| TPST | Tempest Therapeutics | 1.04 | ||||
| TIL | Instil Bio | 9.39 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |